# Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients

> **NCT00481923** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 156 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** rimonabant (SR141716)

## Key facts

- **NCT ID:** NCT00481923
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481923, "Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00481923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*